Target Price | GBP0.83 |
Price | GBP0.79 |
Potential |
4.58%
register free of charge
|
Number of Estimates | 9 |
9 Analysts have issued a price target Dr Martens 2026 .
The average Dr Martens target price is GBP0.83.
This is
4.58%
register free of charge
GBP1.20
51.52%
register free of charge
GBP0.67
15.62%
register free of charge
|
|
A rating was issued by 12 analysts: 6 Analysts recommend Dr Martens to buy, 6 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Dr Martens stock has an average upside potential 2026 of
4.58%
register free of charge
|
Mar '25 |
2026 Estimates |
|
---|---|---|
Revenue Million GBP | 787.60 | 849.73 |
10.20% | 7.89% | |
EBITDA Margin | 18.08% | 20.49% |
20.19% | 13.33% | |
Net Margin | 0.57% | 5.88% |
92.76% | 929.13% |
9 Analysts have issued a sales forecast Dr Martens 2026 . The average Dr Martens sales estimate is
This results in the following potential growth metrics:
9 Analysts have issued an Dr Martens EBITDA forecast 2026. The average Dr Martens EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 Dr Martens Analysts have issued a net profit forecast 2026. The average Dr Martens net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Mar '25 |
2026 Estimates |
|
---|---|---|
Earnings Per Share GBP | 0.00 | 0.05 |
100.00% | ||
P/E | 15.25 | |
EV/Sales | 1.18 |
Analyst | Rating | Action | Date |
---|---|---|---|
Deutsche |
Locked
➜
Locked
|
Locked | Jul 11 2025 |
RBC Capital Markets |
Locked
➜
Locked
|
Locked | May 19 2025 |
Analyst Rating | Date |
---|---|
Locked
Deutsche:
Locked
➜
Locked
|
Jul 11 2025 |
Locked
RBC Capital Markets:
Locked
➜
Locked
|
May 19 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.